nodes	percent_of_prediction	percent_of_DWPC	metapath
Sorafenib—PDGFRA—refractive error	0.801	1	CbGaD
Sorafenib—Regorafenib—PDGFRA—refractive error	0.00684	1	CrCbGaD
Sorafenib—ZAK—eye—refractive error	0.00104	0.0781	CbGeAlD
Sorafenib—HIPK3—retina—refractive error	0.00101	0.0757	CbGeAlD
Sorafenib—EPHX2—eye—refractive error	0.000872	0.0654	CbGeAlD
Sorafenib—EPHX2—retina—refractive error	0.000864	0.0649	CbGeAlD
Sorafenib—FLT4—eye—refractive error	0.000787	0.059	CbGeAlD
Sorafenib—MAP3K7—retina—refractive error	0.000728	0.0546	CbGeAlD
Sorafenib—MKNK2—eye—refractive error	0.000712	0.0534	CbGeAlD
Sorafenib—MKNK2—retina—refractive error	0.000706	0.0529	CbGeAlD
Sorafenib—MKNK1—eye—refractive error	0.000703	0.0528	CbGeAlD
Sorafenib—MKNK1—retina—refractive error	0.000697	0.0523	CbGeAlD
Sorafenib—RALBP1—eye—refractive error	0.000643	0.0482	CbGeAlD
Sorafenib—RALBP1—retina—refractive error	0.000637	0.0478	CbGeAlD
Sorafenib—FLT1—eye—refractive error	0.000612	0.0459	CbGeAlD
Sorafenib—RAF1—eye—refractive error	0.000608	0.0456	CbGeAlD
Sorafenib—FLT1—retina—refractive error	0.000606	0.0455	CbGeAlD
Sorafenib—KDR—eye—refractive error	0.000517	0.0388	CbGeAlD
Sorafenib—KDR—retina—refractive error	0.000512	0.0384	CbGeAlD
Sorafenib—CSF1R—eye—refractive error	0.000505	0.0379	CbGeAlD
Sorafenib—PDGFRB—eye—refractive error	0.000447	0.0336	CbGeAlD
Sorafenib—ABCB1—retina—refractive error	0.000123	0.00922	CbGeAlD
Sorafenib—RAF1—Signaling by FGFR—PTEN—refractive error	3.82e-05	0.000213	CbGpPWpGaD
Sorafenib—RAF1—EGF/EGFR Signaling Pathway—PTEN—refractive error	3.82e-05	0.000213	CbGpPWpGaD
Sorafenib—RAF1—Signaling by ERBB2—PTEN—refractive error	3.8e-05	0.000212	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—VIPR2—refractive error	3.79e-05	0.000211	CbGpPWpGaD
Sorafenib—RAF1—DAP12 signaling—PTEN—refractive error	3.78e-05	0.000211	CbGpPWpGaD
Sorafenib—PDGFRB—Focal Adhesion—PTEN—refractive error	3.77e-05	0.000211	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—EBP—refractive error	3.75e-05	0.000209	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—WNT10A—refractive error	3.73e-05	0.000208	CbGpPWpGaD
Sorafenib—PDGFRB—B Cell Activation—PTEN—refractive error	3.7e-05	0.000206	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—VANGL2—refractive error	3.58e-05	0.0002	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—RDH5—refractive error	3.56e-05	0.000199	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—WNT10A—refractive error	3.56e-05	0.000199	CbGpPWpGaD
Sorafenib—RAF1—Signaling by FGFR in disease—PTEN—refractive error	3.56e-05	0.000199	CbGpPWpGaD
Sorafenib—RAF1—DAP12 interactions—PTEN—refractive error	3.56e-05	0.000199	CbGpPWpGaD
Sorafenib—RAF1—Fc epsilon receptor (FCERI) signaling—PTEN—refractive error	3.56e-05	0.000199	CbGpPWpGaD
Sorafenib—KIT—Innate Immune System—PDGFRA—refractive error	3.54e-05	0.000198	CbGpPWpGaD
Sorafenib—MAP3K7—Innate Immune System—PDGFRA—refractive error	3.54e-05	0.000198	CbGpPWpGaD
Sorafenib—MAPK11—Signaling by NGF—PTEN—refractive error	3.54e-05	0.000197	CbGpPWpGaD
Sorafenib—PDGFRB—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	3.54e-05	0.000197	CbGpPWpGaD
Sorafenib—RAF1—Signaling by EGFR—PTEN—refractive error	3.53e-05	0.000197	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—PDGFRA—refractive error	3.53e-05	0.000197	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—RPS27—refractive error	3.52e-05	0.000196	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—RNF111—refractive error	3.51e-05	0.000196	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—TJP2—refractive error	3.51e-05	0.000196	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—CER1—refractive error	3.51e-05	0.000196	CbGpPWpGaD
Sorafenib—BRAF—Signaling by NGF—PTEN—refractive error	3.51e-05	0.000196	CbGpPWpGaD
Sorafenib—RAF1—Signaling by EGFR in Cancer—PTEN—refractive error	3.5e-05	0.000195	CbGpPWpGaD
Sorafenib—RAF1—Signaling by PDGF—PTEN—refractive error	3.48e-05	0.000194	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—PDGFRA—refractive error	3.47e-05	0.000193	CbGpPWpGaD
Sorafenib—KIT—Immune System—PML—refractive error	3.47e-05	0.000193	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—PML—refractive error	3.47e-05	0.000193	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—COL9A1—refractive error	3.46e-05	0.000193	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—COL9A1—refractive error	3.43e-05	0.000191	CbGpPWpGaD
Sorafenib—KIT—Adaptive Immune System—PDGFRA—refractive error	3.4e-05	0.00019	CbGpPWpGaD
Sorafenib—MAP3K7—Adaptive Immune System—PDGFRA—refractive error	3.4e-05	0.00019	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—AXL—refractive error	3.38e-05	0.000189	CbGpPWpGaD
Sorafenib—FGFR1—Innate Immune System—PDGFRA—refractive error	3.36e-05	0.000188	CbGpPWpGaD
Sorafenib—RAF1—Focal Adhesion—PTEN—refractive error	3.36e-05	0.000188	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—DSE—refractive error	3.36e-05	0.000187	CbGpPWpGaD
Sorafenib—RAF1—Integrated Pancreatic Cancer Pathway—PTEN—refractive error	3.35e-05	0.000187	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—EBP—refractive error	3.35e-05	0.000187	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—CER1—refractive error	3.35e-05	0.000187	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—TJP2—refractive error	3.35e-05	0.000187	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—RNF111—refractive error	3.35e-05	0.000187	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—LUM—refractive error	3.34e-05	0.000186	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—LUM—refractive error	3.34e-05	0.000186	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—WNT10A—refractive error	3.33e-05	0.000186	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—PML—refractive error	3.29e-05	0.000184	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—DSE—refractive error	3.28e-05	0.000183	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—PML—refractive error	3.28e-05	0.000183	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—EBP—refractive error	3.27e-05	0.000182	CbGpPWpGaD
Sorafenib—FGFR1—Adaptive Immune System—PDGFRA—refractive error	3.23e-05	0.00018	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—CACNA1D—refractive error	3.21e-05	0.000179	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—CACNA1D—refractive error	3.21e-05	0.000179	CbGpPWpGaD
Sorafenib—KIT—Signaling by NGF—PTEN—refractive error	3.19e-05	0.000178	CbGpPWpGaD
Sorafenib—RAF1—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	3.15e-05	0.000176	CbGpPWpGaD
Sorafenib—RAF1—Disease—RPS27—refractive error	3.13e-05	0.000175	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—TJP2—refractive error	3.13e-05	0.000175	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—CER1—refractive error	3.13e-05	0.000175	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—RNF111—refractive error	3.13e-05	0.000175	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—COL9A1—refractive error	3.12e-05	0.000174	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—COL9A1—refractive error	3.12e-05	0.000174	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—VANGL2—refractive error	3.09e-05	0.000172	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—EBP—refractive error	3.08e-05	0.000172	CbGpPWpGaD
Sorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—refractive error	3.08e-05	0.000172	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—EBP—refractive error	3.05e-05	0.00017	CbGpPWpGaD
Sorafenib—FGFR1—Signaling by NGF—PTEN—refractive error	3.03e-05	0.000169	CbGpPWpGaD
Sorafenib—PDGFRB—Innate Immune System—PDGFRA—refractive error	3.02e-05	0.000169	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling by NGF—PTEN—refractive error	3.02e-05	0.000168	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—PCCA—refractive error	2.99e-05	0.000167	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—PLA2G16—refractive error	2.99e-05	0.000167	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—COL9A1—refractive error	2.96e-05	0.000165	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—PML—refractive error	2.96e-05	0.000165	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—COL9A1—refractive error	2.95e-05	0.000165	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—PCCA—refractive error	2.93e-05	0.000163	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—PLA2G16—refractive error	2.93e-05	0.000163	CbGpPWpGaD
Sorafenib—PDGFRB—Adaptive Immune System—PDGFRA—refractive error	2.9e-05	0.000162	CbGpPWpGaD
Sorafenib—CDK7—Disease—PDGFRA—refractive error	2.89e-05	0.000161	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—WNT10A—refractive error	2.87e-05	0.00016	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—PDGFRA—refractive error	2.87e-05	0.00016	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—DSE—refractive error	2.84e-05	0.000159	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—CYP26A1—refractive error	2.84e-05	0.000158	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—CYP26A1—refractive error	2.84e-05	0.000158	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—LUM—refractive error	2.83e-05	0.000158	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—BMP2—refractive error	2.83e-05	0.000158	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—LUM—refractive error	2.81e-05	0.000157	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—BMP2—refractive error	2.76e-05	0.000154	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—CACNA1D—refractive error	2.72e-05	0.000152	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling by NGF—PTEN—refractive error	2.72e-05	0.000152	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—CER1—refractive error	2.7e-05	0.000151	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—TJP2—refractive error	2.7e-05	0.000151	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—RNF111—refractive error	2.7e-05	0.000151	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—CACNA1D—refractive error	2.7e-05	0.000151	CbGpPWpGaD
Sorafenib—RAF1—Innate Immune System—PDGFRA—refractive error	2.69e-05	0.00015	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—COL9A1—refractive error	2.66e-05	0.000148	CbGpPWpGaD
Sorafenib—RAF1—Immune System—PML—refractive error	2.64e-05	0.000147	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—EBP—refractive error	2.61e-05	0.000146	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—PDGFRA—refractive error	2.59e-05	0.000144	CbGpPWpGaD
Sorafenib—RAF1—Adaptive Immune System—PDGFRA—refractive error	2.59e-05	0.000144	CbGpPWpGaD
Sorafenib—ABCB1—Transmembrane transport of small molecules—TUBB3—refractive error	2.58e-05	0.000144	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—DSE—refractive error	2.54e-05	0.000142	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—COL9A1—refractive error	2.54e-05	0.000142	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—PCCA—refractive error	2.53e-05	0.000141	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—PLA2G16—refractive error	2.53e-05	0.000141	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—DSE—refractive error	2.48e-05	0.000138	CbGpPWpGaD
Sorafenib—RAF1—Signaling by NGF—PTEN—refractive error	2.43e-05	0.000135	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—CYP26A1—refractive error	2.41e-05	0.000134	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—CYP26A1—refractive error	2.39e-05	0.000133	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—COL9A1—refractive error	2.37e-05	0.000132	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—BMP2—refractive error	2.37e-05	0.000132	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—BMP2—refractive error	2.35e-05	0.000131	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—DSE—refractive error	2.33e-05	0.00013	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—DSE—refractive error	2.31e-05	0.000129	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—PDGFRA—refractive error	2.29e-05	0.000128	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—PCCA—refractive error	2.26e-05	0.000126	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—PLA2G16—refractive error	2.26e-05	0.000126	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—PCCA—refractive error	2.21e-05	0.000123	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—PLA2G16—refractive error	2.21e-05	0.000123	CbGpPWpGaD
Sorafenib—EPHX2—Metabolism—PTEN—refractive error	2.16e-05	0.000121	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—BMP2—refractive error	2.14e-05	0.000119	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—BMP2—refractive error	2.14e-05	0.000119	CbGpPWpGaD
Sorafenib—MKNK1—Disease—PTEN—refractive error	2.11e-05	0.000118	CbGpPWpGaD
Sorafenib—BRAF—Disease—PDGFRA—refractive error	2.09e-05	0.000117	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—PLA2G16—refractive error	2.08e-05	0.000116	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—PCCA—refractive error	2.08e-05	0.000116	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—LUM—refractive error	2.08e-05	0.000116	CbGpPWpGaD
Sorafenib—KIT—Immune System—PDGFRA—refractive error	2.06e-05	0.000115	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—PDGFRA—refractive error	2.06e-05	0.000115	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—PLA2G16—refractive error	2.06e-05	0.000115	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—PCCA—refractive error	2.06e-05	0.000115	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—COL9A1—refractive error	2.05e-05	0.000114	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—BMP2—refractive error	2.03e-05	0.000113	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—LUM—refractive error	2.03e-05	0.000113	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—BMP2—refractive error	2.02e-05	0.000113	CbGpPWpGaD
Sorafenib—MAPK11—Innate Immune System—PTEN—refractive error	2.02e-05	0.000113	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—EBP—refractive error	2.01e-05	0.000112	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—CACNA1D—refractive error	2e-05	0.000111	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—DSE—refractive error	1.98e-05	0.00011	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—PDGFRA—refractive error	1.96e-05	0.000109	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—CACNA1D—refractive error	1.95e-05	0.000109	CbGpPWpGaD
Sorafenib—KIT—Disease—PDGFRA—refractive error	1.91e-05	0.000106	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—BMP2—refractive error	1.82e-05	0.000102	CbGpPWpGaD
Sorafenib—KIT—Innate Immune System—PTEN—refractive error	1.82e-05	0.000102	CbGpPWpGaD
Sorafenib—MAP3K7—Innate Immune System—PTEN—refractive error	1.82e-05	0.000102	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—PTEN—refractive error	1.81e-05	0.000101	CbGpPWpGaD
Sorafenib—FGFR1—Disease—PDGFRA—refractive error	1.81e-05	0.000101	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—PTEN—refractive error	1.78e-05	9.93e-05	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—PDGFRA—refractive error	1.77e-05	9.85e-05	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—CYP26A1—refractive error	1.76e-05	9.84e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—PLA2G16—refractive error	1.76e-05	9.83e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—PCCA—refractive error	1.76e-05	9.83e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—PDGFRA—refractive error	1.76e-05	9.82e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—LUM—refractive error	1.76e-05	9.8e-05	CbGpPWpGaD
Sorafenib—KIT—Adaptive Immune System—PTEN—refractive error	1.75e-05	9.75e-05	CbGpPWpGaD
Sorafenib—MAP3K7—Adaptive Immune System—PTEN—refractive error	1.75e-05	9.75e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—BMP2—refractive error	1.74e-05	9.7e-05	CbGpPWpGaD
Sorafenib—FGFR1—Innate Immune System—PTEN—refractive error	1.73e-05	9.63e-05	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—CYP26A1—refractive error	1.72e-05	9.62e-05	CbGpPWpGaD
Sorafenib—PDGFRA—Innate Immune System—PTEN—refractive error	1.72e-05	9.61e-05	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—PDGFRA—refractive error	1.72e-05	9.6e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—CACNA1D—refractive error	1.69e-05	9.43e-05	CbGpPWpGaD
Sorafenib—FGFR1—Adaptive Immune System—PTEN—refractive error	1.66e-05	9.25e-05	CbGpPWpGaD
Sorafenib—PDGFRA—Adaptive Immune System—PTEN—refractive error	1.65e-05	9.23e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—BMP2—refractive error	1.63e-05	9.07e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—PDGFRA—refractive error	1.63e-05	9.07e-05	CbGpPWpGaD
Sorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—refractive error	1.58e-05	8.81e-05	CbGpPWpGaD
Sorafenib—RAF1—Immune System—PDGFRA—refractive error	1.57e-05	8.75e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—LUM—refractive error	1.57e-05	8.75e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Innate Immune System—PTEN—refractive error	1.55e-05	8.66e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—LUM—refractive error	1.53e-05	8.54e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—DSE—refractive error	1.53e-05	8.51e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—CACNA1D—refractive error	1.51e-05	8.42e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—CYP26A1—refractive error	1.49e-05	8.33e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Adaptive Immune System—PTEN—refractive error	1.49e-05	8.31e-05	CbGpPWpGaD
Sorafenib—CDK7—Disease—PTEN—refractive error	1.48e-05	8.28e-05	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—PDGFRA—refractive error	1.48e-05	8.26e-05	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—PTEN—refractive error	1.48e-05	8.23e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—CACNA1D—refractive error	1.47e-05	8.22e-05	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—PDGFRA—refractive error	1.47e-05	8.18e-05	CbGpPWpGaD
Sorafenib—RAF1—Disease—PDGFRA—refractive error	1.45e-05	8.08e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—LUM—refractive error	1.44e-05	8.04e-05	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—refractive error	1.44e-05	8.02e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—LUM—refractive error	1.43e-05	7.97e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—BMP2—refractive error	1.4e-05	7.83e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—CACNA1D—refractive error	1.39e-05	7.74e-05	CbGpPWpGaD
Sorafenib—RAF1—Innate Immune System—PTEN—refractive error	1.38e-05	7.72e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—CACNA1D—refractive error	1.38e-05	7.68e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—PLA2G16—refractive error	1.36e-05	7.59e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—PCCA—refractive error	1.36e-05	7.59e-05	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—PDGFRA—refractive error	1.33e-05	7.45e-05	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—PDGFRA—refractive error	1.33e-05	7.45e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—CYP26A1—refractive error	1.33e-05	7.44e-05	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—PTEN—refractive error	1.33e-05	7.41e-05	CbGpPWpGaD
Sorafenib—RAF1—Adaptive Immune System—PTEN—refractive error	1.33e-05	7.41e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—CYP26A1—refractive error	1.3e-05	7.26e-05	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—PDGFRA—refractive error	1.27e-05	7.07e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—CYP26A1—refractive error	1.23e-05	6.84e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—LUM—refractive error	1.22e-05	6.81e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—CYP26A1—refractive error	1.22e-05	6.78e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—CACNA1D—refractive error	1.18e-05	6.56e-05	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—PTEN—refractive error	1.18e-05	6.56e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—PDGFRA—refractive error	1.14e-05	6.35e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—PDGFRA—refractive error	1.09e-05	6.06e-05	CbGpPWpGaD
Sorafenib—BRAF—Disease—PTEN—refractive error	1.08e-05	6e-05	CbGpPWpGaD
Sorafenib—KIT—Immune System—PTEN—refractive error	1.06e-05	5.91e-05	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—PTEN—refractive error	1.06e-05	5.91e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—CYP26A1—refractive error	1.04e-05	5.79e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—PDGFRA—refractive error	1.01e-05	5.66e-05	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—PTEN—refractive error	1.01e-05	5.61e-05	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—PTEN—refractive error	1e-05	5.6e-05	CbGpPWpGaD
Sorafenib—KIT—Disease—PTEN—refractive error	9.79e-06	5.46e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—LUM—refractive error	9.43e-06	5.26e-05	CbGpPWpGaD
Sorafenib—FGFR1—Disease—PTEN—refractive error	9.29e-06	5.18e-05	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—PTEN—refractive error	9.26e-06	5.17e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—CACNA1D—refractive error	9.08e-06	5.06e-05	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—PTEN—refractive error	9.07e-06	5.06e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—PTEN—refractive error	9.04e-06	5.04e-05	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—PTEN—refractive error	8.84e-06	4.93e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—PDGFRA—refractive error	8.76e-06	4.89e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—PTEN—refractive error	8.35e-06	4.66e-05	CbGpPWpGaD
Sorafenib—RAF1—Immune System—PTEN—refractive error	8.06e-06	4.49e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—CYP26A1—refractive error	8.02e-06	4.47e-05	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—PTEN—refractive error	7.6e-06	4.24e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—refractive error	7.57e-06	4.22e-05	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—PTEN—refractive error	7.53e-06	4.2e-05	CbGpPWpGaD
Sorafenib—RAF1—Disease—PTEN—refractive error	7.44e-06	4.15e-05	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—PTEN—refractive error	6.85e-06	3.82e-05	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—PTEN—refractive error	6.85e-06	3.82e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—refractive error	6.76e-06	3.77e-05	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—PTEN—refractive error	6.5e-06	3.63e-05	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—PTEN—refractive error	6.49e-06	3.62e-05	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—PTEN—refractive error	6.4e-06	3.57e-05	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—PTEN—refractive error	6.4e-06	3.57e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—refractive error	6.16e-06	3.44e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—PTEN—refractive error	5.84e-06	3.26e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—PTEN—refractive error	5.57e-06	3.11e-05	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—PTEN—refractive error	5.43e-06	3.03e-05	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—PTEN—refractive error	5.39e-06	3e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—refractive error	5.27e-06	2.94e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—PTEN—refractive error	5.21e-06	2.91e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—PTEN—refractive error	4.5e-06	2.51e-05	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—PTEN—refractive error	3.98e-06	2.22e-05	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—PTEN—refractive error	3.89e-06	2.17e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—PTEN—refractive error	3.37e-06	1.88e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—PTEN—refractive error	3.01e-06	1.68e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—PTEN—refractive error	2.94e-06	1.64e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—PTEN—refractive error	2.77e-06	1.54e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—PTEN—refractive error	2.74e-06	1.53e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—PTEN—refractive error	2.35e-06	1.31e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—PTEN—refractive error	1.81e-06	1.01e-05	CbGpPWpGaD
